Back
Lyra Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
26
LYRA
Lyra Therapeutics, Inc.
Last Price:
$3.58
Seasonality Move:
3.74%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LYRA is experiencing slight selling pressure.
Lyra Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.72 | Sell |
| 20-day SMA: | 3.83 | Sell |
| 50-day SMA: | 4.68 | Sell |
| 200-day SMA: | 7.03 | Sell |
| 8-day EMA: | 3.72 | Sell |
| 20-day EMA: | 3.88 | Sell |
| 50-day EMA: | 4.59 | Sell |
| 200-day EMA: | 10.55 | Sell |
Lyra Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.23 | Sell |
| Relative Strength Index (14 RSI): | 39.44 | Sell |
| Chaikin Money Flow: | -567 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.35 - 4.09) | Sell |
| Bollinger Bands (100): | (4.32 - 7.28) | Sell |
Lyra Therapeutics, Inc. Technical Analysis
| Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Lyra Therapeutics, Inc. Stock
Is Lyra Therapeutics, Inc. Stock a Buy?
-
Lyra Therapeutics, Inc. share price is 3.58 while LYRA 8-day simple moving average is 3.72, which is a Sell signal.
-
The stock price of LYRA is 3.58 while Lyra Therapeutics, Inc. 20-day SMA is 3.83, which makes it a Sell.
-
Lyra Therapeutics, Inc. 50-day simple moving average is 4.68 while LYRA share price is 3.58, making it a Sell technically.
-
LYRA stock price is 3.58 and Lyra Therapeutics, Inc. 200-day simple moving average is 7.03, creating a Sell signal.
LYRA Technical Analysis vs Fundamental Analysis
Sell
26
Lyra Therapeutics, Inc. (LYRA)
is a Sell
Is Lyra Therapeutics, Inc. a Buy or a Sell?
-
Lyra Therapeutics, Inc. stock is rated a SellThe current Lyra Therapeutics, Inc. [LYRA] share price is $3.58. The Score for LYRA is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
Lyra Therapeutics, Inc. Stock Info
Market Cap:
4.7M
Price in USD:
3.58
Share Volume:
4K
Lyra Therapeutics, Inc. 52-Week Range
52-Week High:
37.50
52-Week Low:
2.84
Sell
26
Lyra Therapeutics, Inc. (LYRA)
is a Sell
Lyra Therapeutics, Inc. Share Price Forecast
-
What is the Lyra Therapeutics, Inc. stock price today?The Lyra Therapeutics, Inc. stock price is 3.58 USD today.
-
Will LYRA stock go up or go down?Lyra Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Lyra Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Lyra Therapeutics, Inc. is overvalued.
Is Lyra Therapeutics, Inc. Stock a Buy?
-
Lyra Therapeutics, Inc. share price is 3.58 while LYRA 8-day exponential moving average is 3.72, which is a Sell signal.
-
The stock price of LYRA is 3.58 while Lyra Therapeutics, Inc. 20-day EMA is 3.88, which makes it a Sell.
-
Lyra Therapeutics, Inc. 50-day exponential moving average is 4.59 while LYRA share price is 3.58, making it a Sell technically.
-
LYRA stock price is 3.58 and Lyra Therapeutics, Inc. 200-day simple moving average is 10.55, creating a Sell signal.
Fundamental Analysis of Lyra Therapeutics, Inc.
Is Lyra Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $62.25 per share, and an increase next year of $0.51 per share.
Technical Analysis of Lyra Therapeutics, Inc.
Should I short Lyra Therapeutics, Inc. stock?
-
LYRA Moving Average Covergence Divergence (MACD) indicator is -0.23, suggesting Lyra Therapeutics, Inc. is a Sell
-
Lyra Therapeutics, Inc. Relative Strength Index (RSI) is 39.44, which suggest Lyra Therapeutics, Inc. is oversold
-
The Bollinger Bands (25) for Lyra Therapeutics, Inc. is (3.35 - 4.09), which suggest Lyra Therapeutics, Inc. is a Sell
-
The Bollinger Bands (100) for Lyra Therapeutics, Inc. is (4.32 - 7.28), which suggest Lyra Therapeutics, Inc. is a Sell
* Lyra Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.